Skip to content

Validation and Reliability of the Turkish Version of the Montreal Cognitive Assessment-Basic (MoCA-B) in Individuals With Low Educational Level

Turkish Validity and Reliability Study of the MoCA-B Test

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07630688
Acronym
MoCA-B Turkish
Enrollment
166
Registered
2026-06-05
Start date
2024-01-01
Completion date
2026-03-30
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavioral and Psychological Symptoms of Dementia, Cognitive, Dementia, Dementia Alzheimer Type, Dementia (Diagnosis), MCI, MCI Conversion to Dementia, Memory, Mild Cognitive Impairment

Keywords

MoCA-B, dementia, turkish, validity, reliability, MCI, MMSE, CDR

Brief summary

This study aimed to evaluate the validity, reliability, and diagnostic accuracy of the Turkish version of MoCA-B in distinguishing healthy controls, mild cognitive impairment (MCI), and dementia patients within a low-education population.

Detailed description

The prevalence of dementia is steadily increasing, and recognizing cognitive impairment at an early stage-especially during mild cognitive impairment (MCI), before full diagnostic criteria for dementia are met-is crucial. Cognitive screening tools used in individuals with low educational levels often fail to detect MCI. The illiterate version of the Mini-Mental State Examination (MMSE) is insufficient for identifying MCI and early dementia, resulting in delayed diagnosis. The MoCA-Basic (MoCA-B), adapted for low-educated populations and translated into Turkish, has not undergone a validation and reliability study; therefore, it is not routinely used in clinical practice. This study aimed to evaluate the validity and reliability of the Turkish MoCA- B in detecting MCI and dementia, and to compare its diagnostic performance with the MMSE and the Clinical Dementia Rating (CDR). This study included 55 patients with MCI, 56 with dementia, and 55 healthy controls (total n=166) who presented to the Dementia and Neurology Clinics of Antalya Training and Research Hospital between January 2024 and November 2025. After a detailed mental status examination, participants underwent MoCA-B, MMSE (illiterate version), and CDR assessments. Internal consistency was measured using Cronbach's alpha, and test-retest reliability using the intraclass correlation coefficient (ICC). Group differences were analyzed with one-way ANOVA and Tukey post hoc testing. Correlations between MoCA-B, MMSE, and CDR were evaluated with Pearson correlation. Diagnostic accuracy was assessed through ROC analyses, and optimal cut- off values were determined using the Youden index.

Interventions

None listed

Sponsors

Antalya Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 50-100 years * Presented with memory complaints and were evaluated in the Neurology/Dementia outpatient clinics of Antalya Training and Research Hospital (Jan 2024-Nov 2025) * Low educational attainment (illiterate to primary school level) * Provided informed consent

Exclusion criteria

* Active psychiatric disorders / active psychopathology * Intracranial mass lesions * Secondary causes of dementia * Severe medical conditions affecting cognition * History of traumatic brain injury

Design outcomes

Primary

MeasureTime frameDescription
MoCA-B cut off pointsat baseline and after 4 weeks (test-retest)Calculating cutoff values for dementia and MCI in untrained individuals using the MoCA-B test.

Secondary

MeasureTime frameDescription
Correlations of MoCA-B total score with MMSE and CDRdata were collected between January 2024 and November 2025.As a secondary endpoint, Pearson correlation (level of relationship) of the MoCA-B total score with MMSE and/or CDR total scores was evaluated to demonstrate concurrent criterion validity.
Subdomain-level analysesData were collected between January 2024 and November 2025The subdomain-level analyses for the MoCA-B test aimed to determine which domains best facilitated diagnostic differentiation by evaluating, using ANOVA and post-hoc tests, whether subtest scores such as executive function, memory, and attention differed significantly between control, HKB, and dementia groups.

Countries

Turkey (Türkiye)

Contacts

STUDY_CHAIRAylin YAMAN, Prof. MD.

Antalya Training and Research Hospital, Neurology Department, University of Health Sciences (SBÜ), Türkiye

STUDY_DIRECTORAli Rıza GÜNDÜZ, MD

Antalya Training and Research Hospital, Neurology Department, University of Health Sciences (SBÜ), Türkiye

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026